CA
ROIV icon

Cetera Advisors’s Roivant Sciences ROIV Stock Holding History

Cetera Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$758K Buy
+71,926
New +$776K 0.01% 1311
2023
Q3 		– Sell
-11,608
Closed -$117K – 1782
2023
Q2 		$117K Sell
11,608
-592
-5% -$5.29K ﹤0.01% 1559
2023
Q1 		$90K Buy
+12,200
New +$100K ﹤0.01% 1572

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Cetera Advisors's ROIV Position: Q1 2024 in Review

Cetera Advisors opened a new position in Roivant Sciences (ROIV) in Q1 2024: 71,926 shares worth $758K. The stake represents 0.01% of the portfolio and ranks #1311 among its holdings. This is a return to the name: Cetera Advisors previously reported a position in ROIV as recently as Q2 2023.

Cetera Advisors first reported a position in ROIV in Q1 2023 and has held it in 3 quarters since. 259 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.

  • Cetera Advisors held 71,926 shares of Roivant Sciences worth $758K as of Q1 2024.
  • Roivant Sciences was a new Cetera Advisors position in Q1 2024.
  • Roivant Sciences made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1311 holding.
  • Cetera Advisors first reported a position in Roivant Sciences in Q1 2023 and has held it in 3 quarters since.
  • 259 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.